文献速递妇产影像

妊娠与COVID-19:药学考量

Pregnancy and COVID-19: pharmacologic considerations.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该综述总结了COVID-19孕妇及哺乳期患者使用常规与试验性药物的证据,内容涉及产前糖皮质激素、硫酸镁、低剂量阿司匹林、血栓预防流程、分娩镇痛与产后镇痛,以及地塞米松、羟氯喹、洛匹那韦/利托那韦、瑞德西韦、单克隆抗体等。地塞米松是目前唯一被证实并推荐用于需机械通气或需补充氧气的COVID-19孕妇的试验性治疗,多种药物的孕期与哺乳期作用仍需进一步评估。

要点

  • 地塞米松是唯一被证实并推荐用于需机械通气或需补充氧气的COVID-19孕妇的试验性治疗。
  • 低剂量阿司匹林在有指征时用于预防胎盘介导的妊娠并发症无禁忌。
  • 椎管内分娩镇痛可减少导致气溶胶化的急诊全身麻醉需求。

核心结论

  • 地塞米松是目前唯一被证实并推荐用于需机械通气或需补充氧气的COVID-19孕妇的试验性治疗。
  • 羟氯喹、洛匹那韦/利托那韦和瑞德西韦可在临床试验范围内用于妊娠期和哺乳期,但非妊娠人群数据未显示获益。
  • 单克隆抗体(托珠单抗)、免疫调节剂(他克莫司)、干扰素、吸入一氧化氮和恢复期血浆在妊娠期和哺乳期的作用需进一步评估。

研究设计与样本

  • 本文为综述,总结COVID-19孕妇及哺乳期患者使用常规与试验性药物的证据。

诊断标准与关键数值

  • 产前糖皮质激素可在妊娠24至34周常规用于促进胎肺成熟,危重患者及小于24周或大于34周者应个体化决定。
  • 硫酸镁可用于预防子痫发作和胎儿神经保护,但在缺氧和肾功能受损者中应谨慎使用。
  • 有指征时使用低剂量阿司匹林预防胎盘介导的妊娠并发症无禁忌。
  • 文中给出COVID-19孕妇血栓预防流程,考虑疾病严重程度、分娩时间与发病时间的关系、住院或门诊状态、基础合并症及抗凝禁忌。
  • 氧化亚氮可在使用适当个人防护装备时用于分娩镇痛,静脉瑞芬太尼患者自控镇痛在呼吸抑制患者中应谨慎使用。

临床应用与阅片要点

  • 椎管内分娩镇痛可宽松使用,以减少导致气溶胶化的急诊全身麻醉需求。
  • 产后镇痛可短期使用非甾体抗炎药,阿片类药物因呼吸抑制风险应谨慎使用。
  • 机械通气孕妇使用神经肌肉阻滞应尽可能缩短时间,临近分娩时应备好拮抗剂。
  • 羟氯喹、洛匹那韦/利托那韦和瑞德西韦可在临床试验范围内用于妊娠期和哺乳期,非妊娠人群数据未显示获益。
  • 单克隆抗体(托珠单抗)、免疫调节剂(他克莫司)、干扰素、吸入一氧化氮和恢复期血浆在妊娠期和哺乳期的作用需进一步评估。

局限性

  • 单克隆抗体(托珠单抗)、免疫调节剂(他克莫司)、干扰素、吸入一氧化氮和恢复期血浆在妊娠期和哺乳期的作用需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

In this review, we summarize evidence regarding the use of routine and investigational pharmacologic interventions for pregnant and lactating patients with coronavirus disease 2019 (COVID-19). Antenatal corticosteroids may be used routinely for fetal lung maturation between 24 and 34 weeks' gestation, but decisions in those with critical illness and those < 24 or > 34 weeks' gestation should be made on a case-by-case basis. Magnesium sulfate may be used for seizure prophylaxis and fetal neuroprotection, albeit cautiously in those with hypoxia and renal compromise. There are no contraindications to using low-dose aspirin to prevent placenta-mediated pregnancy complications when indicated. An algorithm for thromboprophylaxis in pregnant patients with COVID-19 is presented, which considers disease severity, timing of delivery in relation to disease onset, inpatient vs outpatient status, underlying comorbidities and contraindications to the use of anticoagulation. Nitrous oxide may be administered for labor analgesia while using appropriate personal protective equipment. Intravenous remifentanil patient-controlled analgesia should be used with caution in patients with respiratory depression. Liberal use of neuraxial labor analgesia may reduce the need for emergency general anesthesia which results in aerosolization. Short courses of non-steroidal anti-inflammatory drugs can be administered for postpartum analgesia, but opioids should be used with caution due to the risk of respiratory depression. For mechanically ventilated pregnant patients, neuromuscular blockade should be used for the shortest duration possible and reversal agents should be available on hand if delivery is imminent. To date, dexamethasone is the only proven and recommended experimental treatment for pregnant patients with COVID-19 who are mechanically ventilated or who require supplemental oxygen. Although hydroxycholoroquine, lopinavir/ritonavir and remdesivir may be used during pregnancy and lactation within the context of clinical trials, data from non-pregnant populations have not shown benefit. The role of monoclonal antibodies (tocilizumab), immunomodulators (tacrolimus), interferon, inhaled nitric oxide and convalescent plasma in pregnancy and lactation needs further evaluation. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. D'Souza R, Ashraf R, Rowe H, et al. Pregnancy and COVID-19: pharmacologic considerations. Ultrasound Obstet Gynecol. 2021. PMID: 32959455. doi:10.1002/uog.23116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。